Hepatic portal venous delivery of a nitric oxide synthase inhibitor enhances net hepatic glucose uptake.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  American Journal of Physiology. Endocrinology and Metabolism

• Publication date

  2008-04-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1152/ajpendo.00184.2007PMID 18212022
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of the nitric oxide donor SIN-1 on net hepatic glucose uptake in the conscious dog.

  2008cited by this paper
• Chronic blockade of nitric oxide synthesis reduces adiposity and improves insulin resistance in high fat-induced obese mice.

  2007cited by this paper
• Sildenafil reduces L‐NAME‐induced severe hypertension and worsening of myocardial ischaemia–reperfusion damage in the rat

  2007cited by this paper
• Hepatic morphological alterations, glycogen content and cytochrome P450 activities in rats treated chronically with Nω-nitro-L-arginine methyl ester (L-NAME)

  2007cited by this paper
• Postprandial hyperglycaemia and cardiovascular complications of diabetes: an update.

  2006cited by this paper
• Role of nitric oxide mechanisms in gastric emptying of, and the blood pressure and glycemic responses to, oral glucose in healthy older subjects.

  2005cited by this paper
• Effects of renal nerve stimulation on intrarenal blood flow in rats with intact or inactivated NO synthases.

  2005cited by this paper
• Potentiation of L-NAME-induced systemic and renal vasoconstrictor responses by α1-adrenoceptor antagonism

  2005cited by this paper
• 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside causes acute hepatic insulin resistance in vivo.

  2005cited by this paper
• Palytoxin disrupts cardiac excitation-contraction coupling through interactions with P-type ion pumps.

  2004cited by this paper
• Pharmaceutical reversal of insulin resistance.

  2004cited by this paper
• Nonesterified fatty acids and hepatic glucose metabolism in the conscious dog.

  2004cited by this paper
• Insulin sensitivity is mediated by the activation of the ACh/NO/cGMP pathway in rat liver.

  2004cited by this paper
• Activation of 5′-AMP-activated Kinase Is Mediated through c-Src and Phosphoinositide 3-Kinase Activity during Hypoxia-Reoxygenation of Bovine Aortic Endothelial Cells

  2003cited by this paper
• Practice and principles of pharmacodynamic determination of HISS‐dependent and HISS‐independent insulin action: Methods to quantitate mechanisms of insulin resistance

  2003cited by this paper
• Chronic hepatic artery ligation does not prevent liver from differentiating portal vs. peripheral glucose delivery.

  2003cited by this paper
• Hepatic glutathione and nitric oxide are critical for hepatic insulin-sensitizing substance action.

  2003cited by this paper
• Impact of intraportal N(omega)-nitro-L-arginine infusion on hepatic glucose metabolism in total parenteral nutrition-adapted dogs: interaction with infection.

  2002cited by this paper
• Hepatic arterial perfusion decreases intrahepatic shunting and maintains glucose uptake in the rat liver

  2002cited by this paper
• Effect of carotid or aortic baroreceptor denervation on arterial pressure during hemorrhage in conscious dogs.

  2001cited by this paper
• Type 2 diabetes impairs splanchnic uptake of glucose but does not alter intestinal glucose absorption during enteral glucose feeding: additional evidence for a defect in hepatic glucokinase activity.

  2001cited by this paper
• Nitric oxide synthases in vagal neurons are crucial for the regulation of heart rate in awake dogs

  2001cited by this paper
• Combined intraportal infusion of acetylcholine and adrenergic blockers augments net hepatic glucose uptake.

  2000cited by this paper
• Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus.

  2000cited by this paper
• Duration of the hemodynamic effects of N(G)-nitro-L-arginine methyl ester in vivo.

  2000cited by this paper
• Nonhepatic response to portal glucose delivery in conscious dogs.

  2000cited by this paper
• Mice with gene disruption of both endothelial and neuronal nitric oxide synthase exhibit insulin resistance.

  2000cited by this paper
• Hepatic and gut clearance of catecholamines in the conscious dog.

  1999cited by this paper
• Rapid reversal of the effects of the portal signal under hyperinsulinemic conditions in the conscious dog.

  1999cited by this paper
• Blockade of hepatic nitric oxide synthase causes insulin resistance.

  1999cited by this paper
• A negative arterial-portal venous glucose gradient increases net hepatic glucose uptake in euglycemic dogs.

  1999cited by this paper
• Rapid reversal of the effects of the portal signal under hyperinsulinemic conditions in the conscious dog.

  1999cited by this paper
• Blockade of hepatic nitric oxide synthase causes insulin resistance.

  1999cited by this paper
• Banting Lecture 1997. Control of glucose uptake and release by the liver in vivo.

  1999cited by this paper
• A negative arterial-portal venous glucose gradient increases net hepatic glucose uptake in euglycemic dogs.

  1999cited by this paper
• A negative arterial-portal venous glucose gradient decreases skeletal muscle glucose uptake.

  1998cited by this paper
• Nitric oxide inhibits glycogen synthesis in isolated rat hepatocytes.

  1998cited by this paper
• A negative arterial-portal venous glucose gradient decreases skeletal muscle glucose uptake.

  1998cited by this paper
• Hepatic and muscle glucose metabolism during total parenteral nutrition: impact of infection.

  1998cited by this paper
• Role of nitric oxide in the regulation of the hepatic microcirculation in vivo.

  1997cited by this paper
• Comparison of the direct and indirect effects of epinephrine on hepatic glucose production.

  1997cited by this paper
• Physiological changes in circulating glucagon alter hepatic glucose disposition during portal glucose delivery.

  1997cited by this paper
• Comparison of the time courses of insulin and the portal signal on hepatic glucose and glycogen metabolism in the conscious dog.

  1996cited by this paper
• Failure of glucagon suppression contributes to postprandial hyperglycaemia in IDDM

  1995cited by this paper
• Intraportal glucose delivery alters the relationship between net hepatic glucose uptake and the insulin concentration.

  1991cited by this paper
• Glucoregulatory responses in normal and diabetic dogs recorded by a new tracer method.

  1971cited by this paper
• Measurement of size and turnover rate of body glucose pool by the isotope dilution method.

  1956cited by this paper

• Systemic inhibition of nitric oxide synthesis in non-diabetic individuals produces a significant deterioration in glucose tolerance by increasing insulin clearance and inhibiting insulin secretion

  2013cites this paper
• Regulation of hepatic glucose uptake and storage in vivo.

  2012cites this paper
• Impaired Regulation of Hepatic Glucose Disposition by High Dietary Fat and Fructose

  2011cites this paper
• Functional MRI of liver using BOLD MRI: Effect of glucose

  2010cites this paper
• A Soluble Guanylate Cyclase–Dependent Mechanism Is Involved in the Regulation of Net Hepatic Glucose Uptake by Nitric Oxide in Vivo

  2010cites this paper